| NASDAQ (NMS) Exchange | United States Country |
The fund described focuses on investing in the United States healthcare sector, aiming to leverage the opportunities presented by companies involved in the advancement of healthcare through discovery, development, production, or distribution of healthcare-related products or services. With a strategic approach directed towards equity securities, the fund operates under the advice of its Adviser, maintaining a significant portion of its assets—in excess of 25%—invested in healthcare industries. This targeted investment strategy underlines the fund's commitment to capitalizing on the growth and innovation prevalent in the healthcare sector, targeting companies that are at the forefront of medical and healthcare advancements.
The fund offers the following investment products and services catering to investors interested in the healthcare sector:
Primarily focuses on purchasing equity securities. This includes stocks in companies engaged in healthcare, leveraging the growth potential of the healthcare sector for investors. Equity investments are chosen based on their potential for appreciation, income, or both, aligning with the goal of achieving the fund's investment objective.
By dedicating more than 25% of its total assets to the healthcare sector, the fund is deeply anchored in healthcare industries. This concentration allows it to benefit directly from advancements and innovations within the healthcare field, from medical research and drug development to healthcare services and technology.